ResMed Inc.
RMD
NYSE·Healthcare·Medical - Instruments & Supplies·Mkt cap $33.1B
$228.35
▼ -0.37%
P/E
22.52
Mkt Cap
$33.1B
52-Wk Range
$180.27–$284.87
52-Week Range
$180.27 - $284.87
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 18.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Advanced proprietary medical technologies
- Global distribution network across 140 countries
- Comprehensive cloud-based patient management platform
- Strong intellectual property portfolio
Bear Case
1 risk
- Low volatility (beta 0.8).
Growth
Stable outlook
Rising global sleep apnea diagnosis rates
Value
Fairly valued vs Medical Devices peers
Momentum
Strong
+18.2% over 3m
Quality
Excellent
Excellent business quality
Dividend
Modest
1.08% yield
Smart-money signal
Who's buying RMD right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 29, 2026
AUG 6, 2026
Reported EPS of $2.95 vs $2.89 consensus (+2.1% surprise). Revenue of $1.5B vs $1.5B expected (+0.2%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+2.1%
Revenue trend · last 8Q
—
+10%
+8%
+10%
+9%
+11%
+11%
+9%
Q1 24
Q2 24
Q3 25
Q4 25
Q1 25
Q2 25
Q3 26
Q4 26
$1.2B
$1.3B
$1.3B
$1.3B
$1.3B
$1.4B
$1.4B
$1.5B
Margins · last 8Q
Gross
58.4%
Operating
30.7%
Profit
26.2%
Wall Street consensus
5 analysts · 40% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
40%
Hold
60%
Sell
0%
Median Price Target
—
Latest: KeyBanc · Aug 31, 2026
vs Industry
How RMD stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related